SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000891293-22-000031
Filing Date
2022-06-16
Accepted
2022-06-16 16:18:00
Documents
5
Effectiveness Date
2022-06-16

Document Format Files

Seq Description Document Type Size
1 S-8 cti-formsx8xjune2022.htm S-8 69037
2 EX-FILING FEES exhibit1071s-82022.htm EX-FILING FEES 22048
3 EX-5.1 exhibit51s-82022.htm EX-5.1 8190
4 EX-23.1 exhibit232s-82022.htm EX-23.1 2402
5 image.jpg GRAPHIC 22708
  Complete submission text file 0000891293-22-000031.txt   134171
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265655 | Film No.: 221020801
SIC: 2834 Pharmaceutical Preparations